Diagnostic Role of Circulating microRNAs in Small Testicular Masses Suitable for Testis Sparing Surgery and Post-chemotherapy Residual Masses Suitable for Retroperitoneal Lymph Node Dissection.

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The purpose of this study is to evaluate the diagnostic performance of circulating microRNAs in detecting the presence of germ cell cancer in patients with small testicular mass or retroperitoneal post-chemotherapy residual mass and suitable for testis sparing surgery and retroperitoneal lymph node dissection, respectively.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \>= 18 years

• Single testicular lesion, with \< 2 cm diameter and \< 30 % testicular volume involvement;

• Negative Serum Tumour Markers;

• Suitable for testis sparing surgery;

• Informed consent.

• Age \>= 18 years

• Single/multiple post-chemotherapy retroperitoneal lymph node lesion, with \> 1 cm (non seminomatous) / \> 3 cm (seminomatous) diameter in patients with previous testicular germ cell primary tumour;

• Negative Serum Tumour Markers;

• Suitable for retroperitoneal lymph node dissection;

• Informed consent.

Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola
RECRUITING
Bologna
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 60
Treatments
A
Small testicular mass suitable for testis sparing surgery.
B
Retroperitoneal post-chemotherapy residual mass suitable for retroperitoneal lymph node dissection.
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna

This content was sourced from clinicaltrials.gov